Riskpilot← Back to searchSign inGet full accessMedster AB
ABActiveOrg 5568650328Ängsdalsgatan 6Business and other management consultancy activities · NACE 7020Est. 20110 employees
Revenue 2024
SEK 1,8M
-39% vs 2023
EBITDA margin
8.5%
-92% vs 2023
Equity ratio
94.0%
Financial strength
Net profit 2024
SEK 157K
-90% vs 2023
| Revenue | SEK 1,8M | -39% |
| EBITDA | SEK 151K | -92% |
| Net profit | SEK 157K | -90% |
| Total assets | SEK 2,5M | -32% |
| Equity | SEK 2,4M | -13% |
| Employees | 0 | — |
Legal name
Medster AB
Org number
5568650328
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
19 september 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget ska bedriva konsultverksamhet inom sjukvård och medicinsk verksamhetsutveckling, processanalys, it-utveckling, förvaltning av lös och fast egendom samt tillhörande verksamhet.
Address
Ängsdalsgatan 6
Email
john.terlinder@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 727 | 3 172 | 3 218 | 3 778 | 3 117 | 2 922 | 1 773 |
| Staff expenses | — | — | — | — | — | — | — | −1 568 | −708 | −1 216 |
| EBITDA | −1 | −2 | 38 | 168 | 1 364 | 681 | 1 794 | 948 | 1 929 | 151 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | — | — |
| EBIT | −1 | −2 | 38 | 168 | 1 364 | 681 | 1 794 | 948 | 1 929 | 151 |
| Net financials | — | — | — | — | −1 | −2 | −4 | −3 | 3 | 49 |
| Profit before tax | −1 | −2 | 38 | 128 | 1 019 | 1 063 | 1 790 | 945 | 1 932 | 200 |
| Tax | −0 | −0 | −0 | −29 | −221 | −238 | −370 | −195 | −398 | −43 |
| Net profit | −1 | −2 | 38 | 99 | 798 | 825 | 1 420 | 749 | 1 534 | 157 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 | 5 | 47 | 580 | 2 162 | 2 144 | 2 457 | 2 455 | 3 698 | 2 521 |
| Equity | 1 | −1 | 37 | 136 | 934 | 959 | 1 579 | 1 628 | 2 712 | 2 369 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 6 | 6 | 10 | 404 | 843 | 1 185 | 878 | 827 | 986 | 152 |
| Total debt | 6 | 6 | 10 | 404 | 843 | 1 185 | 878 | 827 | 986 | 152 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20152024
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
20152024
Return on equity
6.6%
This company
18.4%
Market median
-64% vs market
20152024
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20152024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20152024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
KF | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medster AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Magnus Terlinder | Chief Executive Officer | 0 companies |
| Karin Frida Sofie Rudengren | Audit | 0 companies |
| Emelie Anna-May Terlinder | Deputy Board Member | 0 companies |
| Bo Ingemar Claesson | Deputy Board Member | 0 companies |